[go: up one dir, main page]

SI3261679T1 - Genska terapija za izboljšanje vida - Google Patents

Genska terapija za izboljšanje vida

Info

Publication number
SI3261679T1
SI3261679T1 SI201631710T SI201631710T SI3261679T1 SI 3261679 T1 SI3261679 T1 SI 3261679T1 SI 201631710 T SI201631710 T SI 201631710T SI 201631710 T SI201631710 T SI 201631710T SI 3261679 T1 SI3261679 T1 SI 3261679T1
Authority
SI
Slovenia
Prior art keywords
gene therapy
improve vision
vision
improve
therapy
Prior art date
Application number
SI201631710T
Other languages
English (en)
Inventor
Matteo Rizzi
Robin Ali
Alexander Smith
Koji Nishiguchi
Original Assignee
UCL Business Ltd,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd, filed Critical UCL Business Ltd,
Publication of SI3261679T1 publication Critical patent/SI3261679T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI201631710T 2015-02-23 2016-02-19 Genska terapija za izboljšanje vida SI3261679T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201503008A GB201503008D0 (en) 2015-02-23 2015-02-23 Treatment
EP16706413.8A EP3261679B1 (en) 2015-02-23 2016-02-19 Gene therapy to improve vision
PCT/GB2016/050419 WO2016135457A1 (en) 2015-02-23 2016-02-19 Gene therapy to improve vision

Publications (1)

Publication Number Publication Date
SI3261679T1 true SI3261679T1 (sl) 2023-09-29

Family

ID=52822045

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201631710T SI3261679T1 (sl) 2015-02-23 2016-02-19 Genska terapija za izboljšanje vida

Country Status (29)

Country Link
US (3) US20180030477A1 (sl)
EP (1) EP3261679B1 (sl)
JP (1) JP6771474B2 (sl)
KR (1) KR102272466B1 (sl)
CN (1) CN107530449A (sl)
AU (2) AU2016225277B2 (sl)
CA (1) CA2977464C (sl)
CY (1) CY1126098T1 (sl)
DK (1) DK3261679T3 (sl)
EA (1) EA201791900A1 (sl)
ES (1) ES2947308T3 (sl)
FI (1) FI3261679T3 (sl)
GB (1) GB201503008D0 (sl)
HK (1) HK1248594A1 (sl)
HR (1) HRP20230775T1 (sl)
HU (1) HUE062319T2 (sl)
IL (1) IL254066B (sl)
LT (1) LT3261679T (sl)
MX (1) MX2017010772A (sl)
MY (1) MY186444A (sl)
PH (1) PH12017501525B1 (sl)
PL (1) PL3261679T3 (sl)
PT (1) PT3261679T (sl)
RS (1) RS64372B1 (sl)
SG (2) SG11201706822XA (sl)
SI (1) SI3261679T1 (sl)
SM (1) SMT202300200T1 (sl)
WO (1) WO2016135457A1 (sl)
ZA (1) ZA201706440B (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018055131A1 (en) * 2016-09-22 2018-03-29 Universite Pierre Et Marie Curie (Paris 6) Optogenetically transformed photoreceptor precursor cells for the use in the treatment of retinal degenerative diseases
WO2023280388A1 (en) * 2021-07-06 2023-01-12 Institute Of Molecular And Clinical Ophthalmology Basel Promoter for specific expression of genes in rod photoreceptors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1381276A4 (en) * 2001-04-13 2005-02-02 Univ Pennsylvania METHOD FOR TREATMENT OR DEVELOPMENT SLUDGE DEGRADATION
US8470790B2 (en) * 2006-05-04 2013-06-25 Wayne State University Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
JP2011516091A (ja) * 2008-04-18 2011-05-26 ノバルティス・フォルシュングスシュティフトゥング・ツヴァイクニーダーラッスング・フリードリッヒ・ミーシェー・インスティトゥート・フォー・バイオメディカル・リサーチ 失明の治療のための新規な治療用ツールおよび方法
GB2498325B (en) * 2010-10-15 2018-05-02 Eos Neuroscience Inc Engineered human GRM6 enhancer sequence for use in eye therapies
US8957028B2 (en) * 2010-11-13 2015-02-17 Massachusetts Institute Of Technology Red-shifted opsin molecules and uses thereof
WO2012167109A2 (en) * 2011-06-03 2012-12-06 Massachusetts Eye & Ear Infirmary Rpgrip1 gene therapy for leber congenital amaurosis
US20150038557A1 (en) * 2012-02-24 2015-02-05 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and compositions for treatment of retinal degenerative diseases
WO2016019075A1 (en) * 2014-07-29 2016-02-04 Circuit Therapeutics, Inc. System and method for optogenetic therapy

Also Published As

Publication number Publication date
HK1248594A1 (zh) 2018-10-19
HRP20230775T1 (hr) 2023-10-27
US20180030477A1 (en) 2018-02-01
CA2977464C (en) 2022-04-05
EP3261679A1 (en) 2018-01-03
GB201503008D0 (en) 2015-04-08
CA2977464A1 (en) 2016-09-01
ZA201706440B (en) 2021-06-30
MX2017010772A (es) 2018-03-01
DK3261679T3 (da) 2023-06-26
NZ735735A (en) 2021-09-24
EA201791900A1 (ru) 2018-02-28
PH12017501525B1 (en) 2023-08-30
PH12017501525A1 (en) 2018-02-05
CY1126098T1 (el) 2023-11-15
HUE062319T2 (hu) 2023-10-28
CN107530449A (zh) 2018-01-02
SMT202300200T1 (it) 2023-09-06
AU2016225277A1 (en) 2017-10-12
IL254066B (en) 2021-10-31
JP6771474B2 (ja) 2020-10-21
BR112017018062A2 (pt) 2018-04-10
RS64372B1 (sr) 2023-08-31
LT3261679T (lt) 2023-07-10
PT3261679T (pt) 2023-07-04
PL3261679T3 (pl) 2023-09-04
KR20180012737A (ko) 2018-02-06
HK1248595A1 (en) 2018-10-19
ES2947308T3 (es) 2023-08-04
AU2022201553B2 (en) 2024-08-15
SG11201706822XA (en) 2017-09-28
MY186444A (en) 2021-07-22
JP2018506982A (ja) 2018-03-15
AU2016225277B2 (en) 2021-12-09
FI3261679T3 (fi) 2023-06-28
US20250290096A1 (en) 2025-09-18
KR102272466B1 (ko) 2021-07-02
AU2022201553A1 (en) 2022-03-31
WO2016135457A1 (en) 2016-09-01
US20200377907A1 (en) 2020-12-03
IL254066A0 (en) 2017-10-31
SG10202005923WA (en) 2020-07-29
EP3261679B1 (en) 2023-05-03

Similar Documents

Publication Publication Date Title
HRP20190165T1 (hr) Genska terapija za fabryjevu bolest
DK3262066T4 (da) Genterapi
SG11201707663SA (en) Lyophilization of rna
EP4015535C0 (en) GLYCO-ENGINEERING MODIFICATION OF SITE-SPECIFIC TARGETING MOIETIES
HUE040315T2 (hu) Beültethetõ elektróda elrendezés
DK3107563T3 (da) Glycomålrettede terapeutiske midler
SI3104854T1 (sl) Stabilizatorji mastocitov za zdravljenje pljučnih bolezni
EP3209331C0 (en) OPHTHALMIC SOLUTION
LT3149345T (lt) Būdas dviem objektams sujungti
PL3186244T3 (pl) Analogi dioksolanowe urydyny w leczeniu raka
LT3237432T (lt) Baltymo gamyba
EP3037812C0 (en) ENZYME ELECTRODE
EP3185746C0 (en) VISION ENHANCEMENT SYSTEMS
PL3612237T3 (pl) Terapia genowa
PT3353336T (pt) Elétrodo
DK3179007T3 (da) Justerbar glasskinnekonstruktion
DK3304059T3 (da) Nervekultursystem
DK3122763T3 (da) Antimikrobielle peptiddendrimerer
IL249254A0 (en) Gene expression system
EP3137649C0 (en) METALLIZATION OF SURFACES
FR3024647B1 (fr) Transat de puericulture
SI3261679T1 (sl) Genska terapija za izboljšanje vida
DK3207165T3 (da) Gentagne fed-batch dyrkningsfremgangsmåder
FR3025818B1 (fr) Nez de marche eclaire
EP3335072A4 (en) MULTI-CHANNEL OPTOMECHANICAL STIMULATION